YingYing Tong

YingYing Tong


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2023 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
YXYaoxian Xiang
Yaoxian Xiang
CZChan Zhang
Chan Zhang
JWJing Wang
Jing Wang
YCYurong Cheng
Yurong Cheng
LWLi Wang
Li Wang
DYDong Yan
Dong Yan
Background: There are many studies indicating that alterations in the abundance of certain gut microbiota are associated with colorectal cancer (CRC). However, a causal relationship has not been identified due to confounding factors such as lifestyle, environmental, and possible reverse causal associations between the two. Furthermore, certain host gene mutations can also contribute to the development of CRC. However, the association between genes and gut microbes in patients with CRC has not been extensively studied. Methods: We conducted a two-sample Mendelian randomization (MR) study to reveal the causal relationship between gut microbiota and CRC. We obtained SNPs associated with gut microbiome abundance as instrumental variables (IVs) from a large-scale, multi-ethnic GWAS study, and extracted CRC-related datasets from an East Asian Population genetic consortia GWAS (AGWAS) study and FinnGen consortium, respectively. We analyzed a total of 166 bacterial features at four taxonomic levels, including order, family, genus, and species. The inverse-variance-weighted (IVW), weighted median, MR-Egger, and simple median methods were applied to the MR analysis, and the robustness of the results were tested using a series of sensitivity analyses. We extracted IVs of gut microbiota with direct causal association with CRC for SNP annotation to identify the genes in which these genetic variants were located to reveal the possible host gene-microbiome associations in CRC patients. Results: The findings from our MR analysis based on CRC-associated GWAS datasets from AGWAS revealed causal relationships between 6 bacterial taxa and CRC at a locus-wide significance level (P < 1 × 10–5). The IVW method found that family Porphyromonadaceae, genera Anaerotruncus, Intestinibacter, Slackia, and Ruminococcaceae UCG004, and species Eubacterium coprostanoligenes group were positively associated with CRC risk, which was generally consistent with the results of other complementary analyses. The results of a meta-analysis of the MR estimates from the AGWAS and the FinnGen datasets showed that family Porphyromonadaceae and genera Slackia, Anaerotruncus, and Intestinibacter replicated the same causal association. Sensitivity analysis of all causal associations did not indicate significant heterogeneity, horizontal pleiotropy, or reverse causal associations. We annotated the SNPs at a locus-wide significance level of the above intestinal flora and identified 24 host genes that may be related to pathogenic intestinal microflora in CRC patients. Conclusion: This study supported the causal relationship of gut microbiota on CRC and revealed a possible correlation between genes and pathogenic microbiota in CRC. These findings suggested that the study of the gut microbiome and its further multi-omics analysis was important for the prevention and treatment of CRC.

16 September 2024 in Cell & Bioscience
Verified
Journal Article
Open access
XLXin Liu
Xin Liu
JWJing Wang
Jing Wang
YXYaoxian Xiang
Yaoxian Xiang
KWKangjie Wang
Kangjie Wang
DYDong Yan
Dong Yan
YTYingYing Tong
YingYing Tong
O-linked-N-acetylglucosaminylation (O-GlcNAcylation) is a common and important post-translational modification (PTM) linking O-linked β-N-acetylglucosamine (O-GlcNAc) to serine and threonine residues in proteins. Extensive research indicates its impact on target protein stability, activity, and interactions. O-linked N-acetylglucosamine transferase (OGT) is a critical enzyme that catalyzes O-GlcNAc modification, responsible for adding O-GlcNAc to proteins. OGT and O-GlcNAcylation are overexpressed in many tumors and closely associated with tumor growth, invasion, metabolism, drug resistance, and immune evasion. This review delineates the biochemical functions of OGT and summarizes its effects and mechanisms in tumors. Targeting OGT presents a promising novel approach for treating human malignancies.

28 April 2022 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
YTYingYing Tong
YingYing Tong
ZZZheng Zhang
Zheng Zhang
YCYurong Cheng
Yurong Cheng
JYJing Yang
Jing Yang
CFCong Fan
Cong Fan
DYDong Yan
Dong Yan
The transcriptional regulator nuclear factor of activated T-cells, cytoplasmic 3 (NFATc3) is constitutively activated in several cancer types and plays important roles in cancer development and progression. Heavily phosphorylated NFATc3 resides in the cytoplasm of resting cells, and dephosphorylated NFATc3 translocates to the nucleus to activate expression of target genes in cells exposed to stimuli, for instance, hypoxia. Apart from phosphorylation, various post-translational modifications have been reported to regulate NFAT transcriptional activity. However, the mechanisms remain elusive. Here, we have demonstrated that NFATc3 is activated in human pancreatic ductal adenocarcinoma (PDAC) cells and that excessive activation of NFATc3 is correlated to advanced stages of PDAC and short survival time of PDAC patients. NFATc3 is deSUMOylated at K384 by SENP3 under hypoxia, which impairs the interaction between NFATc3 and phosphokinase GSK-3β, subsequently decreases NFATc3 phosphorylation and increases its nuclear occupancy. Knockdown of SENP3 greatly decreased hypoxia-induced NFATc3 nuclear occupancy. Our results highlight that SENP3-mediated deSUMOylation acts as an essential modulator of NFATc3, which is instrumental in PDAC tumor progression under hypoxia.

16 December 2021 in Protein & Cell
Verified
Journal Article
Open access
PDF file
QMQingxia Ma
Qingxia Ma
HJHongfei Jiang
Hongfei Jiang
LMLeina Ma
Leina Ma
YMYing Meng
Ying Meng
DGDong Guo
Dong Guo
ZLZhimin Lu
Zhimin Lu
Of the 20 ribosomally coded amino acid residues, lysine (K) can be frequently and uniquely modified by many types of posttranslational acylation, including acet

27 December 2025 in International Immunopharmacology
Verified
Journal Article
Open access
YTYingYing Tong
YingYing Tong
QLQian Liu
Qian Liu
ZZZezhou Zhao
Zezhou Zhao
KWKangjie Wang
Kangjie Wang
JWJing Wang
Jing Wang
XLXin Liu
Xin Liu
Hepatocellular carcinoma (HCC) is a highly aggressive liver malignancy with poor prognosis and limited therapeutic options. Methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2 (MTHFD2), a mitochondrial enzyme involved in one‑carbon metabolism, is frequently upregulated in cancers; however, its role and regulatory mechanisms in HCC remain poorly defined. In this study, we show that MTHFD2 is significantly overexpressed in HCC and correlated with increased tumor cell proliferation and poor prognosis. MTHFD2 knockdown significantly impaired HCC cell proliferation, invasion, and metastasis, while enhancing CD8+ T cell-mediated cytotoxic responses. Mechanistically, UBE2C facilitated PTEN ubiquitination and subsequent degradation, leading to activation of the PI3K/AKT/mTOR signaling cascade and upregulation of MTHFD2 transcription mediated by transcription factor ATF4. MTHFD2 maintained redox homeostasis and upregulated PD-L1 expression, thereby driving tumor development. Inhibition of the UBE2C-MTHFD2 axis suppressed HCC development in vivo models. Furthermore, expression levels of UBE2C and MTHFD2 are positively correlated and independently associated with poor prognosis in HCC patients. Collectively, these findings establish UBE2C as a key upstream regulator of MTHFD2 and highlight MTHFD2 as a promising therapeutic target for HCC.

19 December 2023 in Global Medical Genetics
Verified
Journal Article
Open access
PDF file
YXYaoxian Xiang
Yaoxian Xiang
LWLi Wang
Li Wang
YCYurong Cheng
Yurong Cheng
HAHuanjuan An
Huanjuan An
CZChan Zhang
Chan Zhang
DYDong Yan
Dong Yan
The aim of the study was to evaluate the potential diagnostic and prognostic value of gene, Poly A-Binding Protein Interacting Protein 2B (PAIP2B) in pancreatic cancer. We used the gene expression data and clinical information of pancreatic adenocarcinoma patients from The Cancer Genome Atlas database and Gene Expression Omnibus database to analyze the expression of PAIP2B in pancreatic cancer samples, and validated the expression of PAIP2B in tumor tissue, using bioinformatics technology to explore the prognostic value of PAIP2B and its possible biological function. A significantly lower level of PAIP2B was observed in pancreatic cancer patients than in controls, and validated by immunohistochemistry. PAIP2B reduced the proliferation and invasion of cancer cells and had a significantly high expression in early stage. Patients with lower levels of PAIP2B had a significantly shorter median survival time than those with higher levels. DNA demethylation played an important role in PAIP2B expression. In addition, PAIP2B expression was significantly associated with the tumor-infiltrating immune cells, especially T cells CD8, T cells CD4 memory resting, macrophages M0, and dendritic cells resting. Our study also found that PAIP2B regulated miRNA function leading to disease progression in pancreatic cancer patients. Our study explored the potential value of PAIP2B as a biological link between prognosis and pancreatic cancer, and provided reference for the follow-up study on the role of PAIP2B in pancreatic cancer.